Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status
AIDS Jun 07, 2018
Presti RM, et al. - The oral bacterial microbiome was characterized in HIV-infected participants at baseline and after 24 weeks of EFV/FTC/TDF. On assessing 35 participants, co-enrolled in two AIDS Clinical Trials Group (ACTG) studies, A5272 and A5280, with paired saliva samples and complete data sets, researchers noted variation regarding both the number of taxa detected and the average alpha diversity between participants at baseline, however, the participants were not significantly different in terms of CD4+ cell count, viral load or other factors. Participants with persistently low CD4+ T-cell counts showed markedly higher bacterial richness and diversity after 24 weeks of ART. Observations suggest that shifts in the oral microbiome following ART initiation are complex. In immune function and inflammatory disease, these shifts might have a significant role.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries